See more : Heska Corporation (HSKA) Income Statement Analysis – Financial Results
Complete financial analysis of Khiron Life Sciences Corp. (KHRWF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Khiron Life Sciences Corp., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- GoGold Resources Inc. (GGD.TO) Income Statement Analysis – Financial Results
- PT Saraswanti Anugerah Makmur, Tbk (SAMF.JK) Income Statement Analysis – Financial Results
- FCS Software Solutions Limited (FCSSOFT.BO) Income Statement Analysis – Financial Results
- Group Nine Acquisition Corp. (GNACW) Income Statement Analysis – Financial Results
- Intergis Co., Ltd (129260.KS) Income Statement Analysis – Financial Results
Khiron Life Sciences Corp. (KHRWF)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
About Khiron Life Sciences Corp.
Khiron Life Sciences Corp. operates as an integrated medical and cannabis company in Latin America and Europe. It operates through Health Services, Medical Cannabis Products, and Wellbeing Products segments. The company focuses on the cultivation, production, distribution, and export of tetrahydrocannabinol and cannabidiol (CBD) medical cannabis. It also operates a network of health centers and satellite clinics under the ILANS and Zerenia brands; develops CBD-based cosmeceutical products under the Kuida brand name; and operates Zerenia clinic in Medellin and Peru. Khiron Life Sciences Corp. was incorporated in 2012 and is headquartered in Vancouver, Canada.
Source: https://incomestatements.info
Category: Stock Reports